Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

Advances in Laboratory Medicine - Avances en Medicina de Laboratorio is a distinguished open-access journal published by Walter de Gruyter GmbH, dedicated to the field of medical laboratory technology and the broader aspects of laboratory medicine. Launched in 2020, this journal aims to disseminate high-quality research, innovative methodologies, and critical reviews that foster advancements in laboratory practices. With significant rankings, including Q3 in Medical Laboratory Technology and Q4 in Education and Medicine (miscellaneous) as of 2023, it serves as a vital resource for researchers, professionals, and students interested in enhancing their understanding and implementation of laboratory protocols. Based in Germany, the journal not only emphasizes accessibility through its open-access model but also contributes significantly to the evolving landscape of medical laboratory science. Join a community of scholars striving to improve patient outcomes and elevate standards within the laboratory domain.

Northern Clinics of Istanbul is an esteemed open-access journal dedicated to advancing knowledge within the field of medicine, specifically focusing on miscellaneous areas of general medicine. Published by KARE PUBL since 2014, it provides a vital platform for researchers, healthcare professionals, and students to share innovative findings and foster academic dialogue. With its ISSN 2148-4902 and E-ISSN 2536-4553, the journal has garnered attention in the academic community, earning a reputable Q4 quartile ranking in the category of Medicine (Miscellaneous) for the year 2023 and a Scopus rank of #497 out of 636. Based in Istanbul, Turkey, the journal is committed to accessibility and relevance, making significant contributions to the global medical discourse. Northern Clinics of Istanbul aims to serve as an interdisciplinary hub for innovative research, promoting the dissemination of knowledge and enhancing collaborative efforts among scholars. Join us in exploring the latest insights that are shaping healthcare today.

International Cardiovascular Research Journal, published by Shiraz University Medical Sciences, serves as a vital platform for the dissemination of cutting-edge research in the field of cardiology and cardiovascular medicine. Since its inception in 2011, this journal has continuously devoted itself to promoting the highest quality of scholarly communication, helping to bridge the gap between laboratory findings and clinical application. With an ISSN of 2251-9130 and an E-ISSN of 2251-9149, it is indexed in prominent databases, contributing to its visibility and accessibility to a global audience. Although currently classified in the Q4 quartile in the 2023 rankings, the journal is committed to enhancing its impact factor and academic stature. It aims to facilitate open access for all published articles, although specific details on access options are pending. Through its rigorous peer-review process and diverse scope—which encapsulates advancements, clinical studies, and innovative therapeutic strategies—this journal fosters academic collaboration in the realm of cardiovascular health, making it an invaluable resource for researchers, practitioners, and students alike.

The Journal of Clinical and Translational Science, published by Cambridge University Press, stands at the forefront of advancing the fields of clinical and translational medicine. With an impressive impact factor denoting its significance within the scientific community, this peer-reviewed, Open Access journal, which has embraced open dissemination of research since 2017, provides a crucial platform for researchers, professionals, and students dedicated to exploring innovative methodologies and translating scientific discoveries into practical applications. Situated in the United Kingdom, the journal reflects a commitment to fostering collaboration and knowledge exchange among scholars, as evidenced by its respectable Q2 ranking in the Medicine (miscellaneous) category and a robust position in Scopus rankings (192 out of 636) with a 69th percentile. Covering a wide scope within clinical and translational domains, it aims to rapidly publish high-quality research, thereby accelerating the translation of laboratory findings into clinical practice. By bridging gaps between disparate research areas, the Journal of Clinical and Translational Science plays a pivotal role in driving medical innovation and improving healthcare outcomes globally.

ANNALS OF MEDICINE, published by Taylor & Francis Ltd, stands as a leading journal in the field of medical research, holding a prestigious Q1 ranking within the miscellaneous medicine category as of 2023. With a focus on disseminating high-quality, peer-reviewed research, the journal provides a vital platform for scholars, clinicians, and policy-makers to share innovative findings that advance the understanding and practice of medicine. Established in 1961, ANNALS OF MEDICINE has continuously evolved, promoting interdisciplinary approaches and fostering collaboration among researchers across various medical specialties. Its impressive Scopus rank of #103 out of 636, representing the top 83rd percentile in general medicine, underscores its influence and importance in the medical community. Although it does not offer Open Access options, the journal remains committed to maintaining rigorous academic standards, making it an essential resource for anyone dedicated to improving healthcare outcomes through scholarly research.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.